Last reviewed · How we verify

NCT06809894: Delirium

Management of Non-pharmacologic Delirium With the Use of a Nursing-led E-health Project: a Randonmized Controlled Trial

Not yet recruiting NA Last updated 29 May 2025
What this trial tests

NA trial testing Application of an action protocol for the management of delirium through the use of non-pharmacological interventions in Delirium Treatment in 65 participants. Not yet recruiting.

Timeline
1 April 2026
Primary endpoint
1 June 2027
15 June 2027

Quick facts

Lead sponsorUniversitat de Lleida
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment65
Start date1 April 2026
Primary completion1 June 2027
Estimated completion15 June 2027
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Universitat de Lleida

Who can join

Adults 80 to 130, any sex, with Delirium Treatment or Delirium Confusional State. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Application of an action protocol focused on the application of non-pharmacological interventions for managing delirium in the process of prevention, diagnosis and treatment, evaluated using an e-health intervention, with a tablet to introduce on it the data about the prevention, diagnostic and treatment process of each recluted patient, in the Igualada Hospital Center, once a day.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Delirium Treatment

Currently open trials in the same condition.

Other Universitat de Lleida trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06809894.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing